Inspyr Therapeutics Inc (OTC Pink - No Information:NSPX)

0.008
Delayed Data
As of May 25
 0.00 / 0.00%
Today’s Change
0.01
Today|||52-Week Range
0.55
-68.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization23.0K23.0K21.0K21.0K
 
 
 
 
 
 
Operating ExpensesGross Income-23.0K-23.0K-21.0K-21.0K
 
 
 
 
 
General Expenses6.4M7.0M6.0M3.2M
 
 
 
 
 
Research And Development2.7M3.7M2.3M1.1M
 
 
 
 
 
Total Operating Expenses6.4M7.0M6.1M3.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.4M-7.0M-6.1M-3.2M
 
 
 
 
 
Extraordinary Credit1.1M0.00181.0K2.5M
 
 
 
 
Interest Expense On Debt3.0K0.00--2.9M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.3M-7.0M-5.9M-3.6M
 
 
 
 
 
Net Income-5.3M-7.0M-5.9M-3.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS827.2K1.0M1.2M1.4M
 
 
 
 
 
Shares To Calculate EPS Diluted827.2K1.0M1.2M1.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.30-$6.90-$5.10-$2.55
 
 
 
 
 
EPS Diluted-$6.30-$6.90-$5.10-$2.55